INTRODUCTION
Hypertension is a major factor contributing to the global disease burden [1, 2] . The worldwide prevalence of HTN in 2000 was ~26%, affecting around 1 billion people. There is considerable variation among countries with regard to the prevalence (~5 to 70 %) and control rates (~5 to 58 %) for hypertension [3] . Poor control of hypertension can result in ischemic heart disease, heart failure, stroke and chronic renal insufficiency [2] .
Major guidelines for hypertension were published in 2003 by World Health Organization /International Society of Hypertension [4] , JNC-7 [5] and European Society of HypertensionEuropean Society of Cardiology [6] .
Several studies have found that only 60 % of patients with known hypertension receive treatment, and in fewer than 50 % of treated patients blood pressure was controlled [7] . In the USA, only one third of patients with hypertension undergoing treatment had their blood pressure controlled [5, 8] . In Jordan during 2004, about 400,000 (15 %) adults reported hypertension [9] . Very few studies have addressed the management of hypertension in this country. A study of prevalence, awareness and management of hypertension in eastern Jordan revealed that 68.5 % of people who were aware of their diagnosis did not achieve control of their blood pressure [10] , and among Bedouins in Northern Jordan, 57.1 % of those aware of their diagnosis did not achieve control [11] .
The objectives of this study include assessment of cardiovascular risk factors prevalence, pattern of antihypertensive drugs use, as well as rate of blood pressure control and factors associated with it among Jordanian patients who attend cardiology clinics.
EXPERIMENTAL

Sampling frame
The cross-sectional observational study was conducted by specially trained field workers in outpatient cardiology clinics in Jordan University Hospital and Al-Basheer Hospital in Amman between January 1 2007 and April 1 2007. Physicians who agreed to participate in the study were asked to enroll adult (18 
Blood pressure measurement and targets
Blood pressure was measured two times on the right arm supported at heart level with a conventional (mercury) sphygmomanometer and correctly-sized cuff with the participant seated after at least 5-min rest, and with 2 min rest between each measurement. Systolic blood pressure was based on the first Korotkoff phase and diastolic blood pressure on the fifth Korotkoff phase. The average of the two readings was used for analysis.
Hypertension was considered to be controlled if systolic blood pressure was < 140 mm Hg and diastolic blood pressure < 90 mm Hg for general hypertensive population, or systolic blood pressure < 130 mm Hg and diastolic blood pressure < 80 mm Hg in patients with established cardiovascular disease, diabetes mellitus or chronic kidney disease [4] [5] [6] .
Statistical analysis
All data were entered and analyzed using the SPSS software (version 16.0; SPSS, Inc, Chicago, IL). Chi square (χ 2 ) was used to test any significance between categorical variables, whereas independent t-test was utilized with noncategorical variables. All p-values were two-sided and p < 0.05 was considered statistically significant. Univariate analysis was used to determine any association of blood pressure control with the categories of patients' factors that were potentially important based on previous research and clinical judgment (patient's gender, age, body mass index, duration of hypertension, smoking status, number of cardiovascular risk factors, presence of cardiovascular disease, diabetes or renal disease, the number and class of antihypertensive medications).
To assess the independent contribution of patient characteristics to the blood pressure control, we conducted multivariate logistic regression analysis for variables which demonstrated significance (p < 0.05) in univariate analysis. Adjusted odds ratio and 95 % confidence intervals for the probability of blood pressure control were calculated for each predictor to explain the strength of association.
RESULTS
Patients' demographic and medical data
The number of patients enrolled was 408. Their general and clinical characteristics are presented in Table 1 . Hypertension was controlled only in 44 % of patients.
Prevalence of modifiable cardiovascular risk factors
Hypertensive patients were checked for modifiable cardiovascular risk factors (smoking, obesity, diabetes mellitus, dyslipidemia and chronic kidney disease). Only 22 patients (5.4 %) had no modifiable risk factors, 107 (26.2 %) had one, 167 (40.9 %) had two, 92 (22.5 %) had three, 20 (4.9 %) had four, and none of the patients had five risk factors. Table 2 shows proportion of patients who were screened by laboratory or other diagnostic tests for presence of cardiovascular risk factors or hypertension complications. Unfortunately, data on electrocardiogram, abdominal ultrasound, echocardiography and fundoscopic examination were not available in medical files. Pattern of antihypertensive medications is shown in Table 4 . The most commonly prescribed class as monotherapy was beta-blockers, followed by angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and calcium channel blockers. Thiazides accounted to a very small number of cases. Similar pattern was observed in the complete sample of patients receiving antihypertensives. Among patient characteristics studied by univariate logistic regression analysis, duration of hypertension, presence of diabetes mellitus, peripheral arterial disease, heart failure and history of acute coronary syndrome were inversely associated, while angiotensin receptor blockers were positively associated with achievement of BP control (Table 5 ). 
Assessment and management of cardiovascular risk factors
Treatment of hypertension
DISCUSSION
The benefit of blood pressure reduction with antihypertensive drug treatment has become increasingly evident, with decreases in both allcause mortality and coronary artery disease as shown by multiple clinical trials and epidemiological studies [12] . In 2004 in the US, blood pressure control rates were 61.4 % in men and 35.1 % in women [13] . In our study, despite the average number of antihypertensive medications being 2.38, the blood pressure control rate was only about 44 %, suggesting that hypertensive patients are not treated aggressively enough.
Comparing our results to other studies conducted in Jordan, blood pressure control rate among hypertensive patients who attend cardiology clinics in Amman, the capital of Jordan (44%), is higher than in eastern Jordan (31 %) [10] , and close to Bedouins in Northern Jordan (43 %) [11] .
Clustering of three or more metabolic syndrome components increases the incidence of cardiovascular disease, and the identification and management of additional risk factors should be encouraged to prevent cardiovascular events in hypertensive patients [14] . Among hypertensive patients in our study, 96.6 % had one or more and 27.4 % had three or more additional risk factors. Our data are in agreement with the finding from the Framingham Heart Study that almost 80 % of patients with hypertension had at least one additional cardiovascular risk factor, while 30 % of men and 32 % of women with hypertension had three or more additional risk factors [15] . Our data also support results from other studies that more than 50 % of hypertensive patients had diabetes, dyslipidemia, or obesity [14, 16] .
Past studies emphasized that assessment of global cardiovascular risk and titration of multiple antihypertensive drugs are considered to be important for achievement of blood pressure goals in the majority of patients [1] . In our study, investigations for assessment and management of cardiovascular risk factors/diseases were not always available -despite high prevalence of cardiovascular and associated diseases such as diabetes mellitus, dyslipidemia, coronary artery disease, heart failure and chronic renal disease.
The prescription patterns of antihypertensives vary from one country to another [17] . In a study conducted in USA in 2004, diuretics were prescribed at a rate of 33%, calcium channel blockers 26%, angiotensin-converting enzyme inhibitors 34%, angiotensin receptor blockers 25%, and beta-blockers 19 % of hypertension visits [18] . In a cross-sectional, population-based survey in Ontario, Canada, of all hypertensives, 51 and 49 % were on monotherapy compared to 2+ drug therapy with similar control rates (86 % vs. 80 % respectively). In those on monotherapy, a renin-angiotensin system blocker was the most commonly used drug class (62 %), and use of other drug classes was only approximately 10 %. In those on 2+ drug therapy, a renin-angiotensin system blocker was also the most common class (80 %), followed by a diuretic (67 %) [19] . In this Our results are consistent with other studies where, despite increased awareness and treatment of hypertension, individuals with a higher risk of coronary artery disease had higher rates of uncontrolled blood pressure compared with the average-risk population [20] . Many other factors are likely to contribute to suboptimal rates of hypertension control: insufficient or inappropriate treatment, lack or unaffordability of drugs, insufficient patient knowledge about disease and/or medications, barriers to implement healthy life style, insufficient follow-up, and poor adherence. Among clinical and medication characteristics studied in multivariate logistic regression analysis, only presence of diabetes mellitus was inversely associated with BP control. In contrast to our results, control rates in Canadian study did not differ in the overall hypertensive population and those with comorbidity [19] .
Limitations of the study
The patient sample, while representative of the population receiving primary care mainly in urban clinic may not be representative of all adults with hypertension in Jordan; consequently, the hypertension control rates and patterns of medication use may be overestimated. Hypertension could be recognized and treated by other specialists, but our data focused on cardiologists. We did not study the effects of patient education level, lifestyle and medication adherence, income and insurance status on the blood pressure control.
Physician's characteristics that may also impact hypertension control were not investigated. In addition, because of the cross-sectional design, there was no assessment whether the present therapy was the initial one or whether it replaced or amended the original one. Another limitation of this study was the possible selection of the individuals at higher cardiovascular risk among people coming to their cardiologists for the treatment of their high blood pressure compared to the general hypertensive population. Still, this group of patients would receive immediate benefit if a more "aggressive" treatment approach was used. Further large interventional studies are needed in hypertensive population in Jordan, addressing all the above issues.
CONCLUSION
The prevalence of cardiovascular risk factors, such as smoking, obesity, diabetes, dyslipidemia, CKD was high in hypertensive patients. Alarmingly, there is inadequate cardiovascular risk assessment and control of blood pressure in hypertensive patients in Jordan. Several practical measures need to be taken urgently: developing national strategic plan to improve hypertension and cardiovascular risk factors control, encouraging patients to maintain healthy lifestyle, pharmacy-directed interventions (e.g., availability and prescription of generic drugs) and initiatives directed toward physicians (e.g., clinical algorithms and simple flowcharts).
